Back to search

Article

Development of Therapies for Rare Genetic Disorders of GPX4: Roadmap and Opportunities

2021-04-05

Abstract excerpt

<h4>Background: </h4> Extremely rare progressive diseases like Sedaghatian-type Spondylometaphyseal Dysplasia (SSMD) can be neonatally lethal and therefore go undiagnosed or are difficult to treat. Recent sequencing efforts have linked this disease to mutations in GPX4, with consequences in the resulting enzyme, glutathione peroxidase 4. This offers potential diagnostic and therapeutic avenues for those suffering...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a67cd64-2b53-5d45-9366-0debdab14ce3
DOI
10.20944/preprints202104.0105.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of Therapies for Rare Genetic Disorders of GPX4: Roadmap and OpportunitiesDOI 10.20944/preprints202104.0105.v1
Select a neighboring publication to make it the new centre.